ARCHIVES

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

“You Can’t Legislate Biology,” Higginson Tells AACI Members

February 9, 1979

In Brief: Treatment Reorganization Will Give Rauscher “Lumps,” He Says; Coordinating Group Favored

August 16, 1974

Center Core Grants Could Face Cuts Of Up To 20%

February 16, 1990

Irinotecan And Carboplatin Improve Response In NSCLC

June 24, 2005

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

FDA Advisors Debate Ban, Black Box And Status Quo of Power Morcellators

July 25, 2014